The active ingredient of a pharmaceutical drug is called an active pharmaceutical ingredient. HPAPI are compounds used to treat diseases such as cancer, hormonal imbalances, respiratory disorders, among others. High performance active pharmaceutical ingredients (HPAPI) are the fastest growing segment of the active ingredient market. Advances in clinical pharmacology and oncology research are some of the main reasons driving the growth of the HPAPI market.
An increasing geriatric population across the globe coupled with lifestyle related diseases in the younger generation are factors that are causing an increase in cancer, diabetes, cardiovascular diseases, among others. In the case of cancer, current treatment methods such as chemotherapy have severe side effects as well as they affect the non cancerous cells. Favorable government regulations are also helping with development of the pipeline of efficient drugs which is further augmenting the HPAPI market. The fact that some of the drugs are approaching patent expiry also positively impacts the market.
The High Performance Active Pharmaceutical Ingredients Market market can be segmented on the basis of type of ingredient as:
The High Performance Active Pharmaceutical Ingredients market can be segmented on the basis of type of drugs as:
Currently, oncology accounts for the largest share of the application market for HPAPI. Rising instances in hormonal imbalance in the femal population is a factor that makes this segment the second largest segment of the overall HPAPI market.
In terms of applications, the High Performance Active Pharmaceutical Ingredients Market has been segmented across the following:
North America currently accounts for the largest share of the HPAPI market while the asia pacific region is expected to grow at the fastest rate till the end of the forecast period considered in this report. Emerging economies in the APAC region are witnessing a rapid growth and development in the healthcare industry owing to increasing awareness levels and spending capacity of people in those countries.
The market has been segmented based on the following geographies:
- North America
- South America
- Middle East
Sample companies are profiled in this report are:
- Sanofi Aventis
- Hospira Inc
- Lonza Group
- BASF AG
- Bristol-Myers Squibb Company